Graziella Pellegrini is Full Professor at the University of Modena and Reggio Emilia and Cell Therapy Program Coordinator at the Centre for Regenerative Medicine "Stefano Ferrari". She was also co-founder of Holostem Terapie Avanzate S.r.l. She has a Master Degree in Chemistry and Pharmaceutical Technologies and a Master Degree in Pharmacy at the University of Genova. She was one of the two inventors of the technology for culture and transplantation of limbal stem cells for the treatment of blindness due to corneal stem cell deficiency; she discussed and obtained the orphan drug designation and European registration of the corneal stem cell therapy. Prof. Pellegrini developed several translational medicine protocols for treatment of third-degree burns, depigmentation disorders and a successful phase I clinical trial on gene therapy of epidermolysis bullosa. She was working with her team, on oral mucosa and urethra for a phase I clinical trial, and research on airway tissue reconstruction and full cornea reconstruction. Author of many patents, book chapters and international peer reviewed publications in the major international peer-review journals, as New England Journal of Medicine, Nature, Lancet, she was invited speaker or chairman in over 250 major scientific meetings all over the world. Prof. Pellegrini is founding member of the International Ocular Surface Society, member of many major scientific societies and international committees, and she was awarded by ISSCR, Termis EU, Italian government, Department of international Trade, Louis Jeantet-Collen Prize and other organizations.